Richard C. Pasternak's most recent trade in Milestone Pharmaceuticals Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | Richard C. Pasternak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Richard C. Pasternak | Director | Purchase of securities on an exchange or from another person at price $ 5.20 per share. | 20 Oct 2022 | 10,000 | 10,000 (0%) | 0% | 5.2 | 52,000 | Common Shares |
| Milestone Pharmaceuticals Inc | Richard C. Pasternak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Richard C. Pasternak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |